PDS Biotech (PDSB) is a clinical-stage immunotherapy company that has a growing pipeline of cancer immunotherapies and infectious disease vaccines. Frank Bedu-Addo, President and CEO of PDS Biotech, gives an overview of PDS Biotech, highlighting its new cancer drug, Versamune, which effectively delivers disease-specific antigens for in vivo uptake and processing. Tune in to find out more.
17 Jun 2021
The Watch List
28 Apr 2022
The Watch List
20 Apr 2022
Morning Trade Live
18 Mar 2022
Trading 360
18 Apr 2022
The Watch List
20 May 2022
Market On Close
05 Apr 2022